eoe sub articles

EoE Sub Articles

1. Coupling Gal4- and QF-mediated Htt Transgene Expression in Drosophila
<ol>
	<li>Collect and/or generate transgenic Drosophila melanogaster lines containing tissue-specific Gal4 or QF &#34;drivers,&#34; as well as lines containing wild-type or mutant Htt transgenes downstream of the Gal4-UAS or QF-QUAS. Ensure that the proteins that are expressed from these transgenes are fused to fluorescent proteins or epitope-tagged to allow for differentiation of mutant and wild-type Htt transgene products in the same fly. See Figure 1. 
	NOTE: We typically use exon 1 fragments of the human Htt gene. However, transgenic flies can instead be generated to express longer Htt fragments or other genes if desired.</li>
	<li>Plan the genetic strategy such that mutant and wild-type Htt transgenes will be expressed in distinct, non-overlapping cell populations.
	<ol>
		<li>If any expression overlap occurs, mutant and wild-type Htt proteins synthesized in the same cells will co-aggregate and prevent detection of prion-like events. To avoid this, use the Gal4 and QF specific repressors, Gal80 and QS40, respectively (Figure 1). Selecting developmentally-controlled Gal4 and/or QF drivers can help to restrict expression of mutant Htt to post-mitotic cells, eliminating the possibility that cell division might contribute to cell-to-cell aggregate spreading.</li>
	</ol>
	</li>
	<li>Using standard culturing conditions, mate the flies to generate progeny that express mutant Htt via QF (or Gal4) in a &#34;donor&#34; cell population and wild-type Htt via Gal4 (or QF) in a &#34;recipient&#34; cell population. See Figure 1 for a schematic showing a possible genetic combination. 
	NOTE: The QF and Gal4 drivers that were used to generate the data shown in Figures 1-4 and in our previous publication include the DA1 olfactory receptor neuron (ORN) driver, Or67d-QF, and the pan-glial driver, repo-Gal4.</li>
	<li>Generate control flies in parallel that express wild-type Htt in both QF- and Gal4-labeled cell populations.</li>
	<li>Collect progeny of the desired genotype and age the animals as appropriate.</li>
</ol>
2. Micro-dissection and Fixation of Adult Drosophila Brains
NOTE: This dissection procedure has been modified from a previous publication and can be used to prepare brains for imaging direct fluorescence signals from Htt-fluorescent protein fusions.
<ol>
	<li>Collect the following materials and place on ice: phosphate-buffered saline containing 0.03% Triton X-100 (PBS/T); microcentrifuge tubes containing 970 &#181;L of 4% paraformaldehyde (PFA) fixative solution prepared by adding 200 &#181;L 20% PFA to 770 &#181;L PBS/T; a clear glass dish containing well; a disposable transfer pipet; two dissecting forceps (one no. 3 and one no. 5).</li>
	<li>Anesthetize the adult flies using CO2 and transfer them to one well of the glass dish on ice.</li>
	<li>Using a transfer pipet, add a small amount (~ 500 &#181;L) of cold PBS/T to the well containing the flies and to an empty well. Avoid introducing too many bubbles, as they can interfere with the dissection.</li>
	<li>Place the glass dish on a flat surface below a dissecting microscope and adjust the magnification until the fly body fills the field of view and is in focus.</li>
	<li>Position a pair of gooseneck light sources so that light is illuminating both sides of the glass dish. Anchor a folded lab tissue under the glass dish to discard body parts/cuticles during the dissection.</li>
	<li>Using the no. 3 forceps in the non-dominant hand, transfer a single fly into the well containing PBS/T. Immobilize the fly by grabbing hold of its abdomen with the ventral side facing up.</li>
	<li>Keeping the fly fully submerged in PBS/T, remove the fly head with the no. 5 forceps in the dominant hand. Insert one tip of these forceps under the cuticle in the small space adjacent to the proboscis on one side of the fly head. Secure the grip on the head by pinching the forceps to grab hold of the eye from both sides.</li>
	<li>Remove the fly head from its body by pulling the two forceps apart. Dispose of the fly body on a lab tissue positioned nearby. Maintain pressure on the dominant-hand forceps so the fly head is not lost.</li>
	<li>Position one tip of the no. 3 forceps in the non-dominant hand in the same small space under the cuticle on the other side of the proboscis. Once positioned, pinch the forceps to grip the eyes in the same location on both sides of the head.</li>
	<li>Once the grip on the cuticle is secure, gently pull the forceps apart at 180&#176;. This action will break apart the head cuticle without damaging the brain. Discard cuticle residue on a lab tissue.
	<ol>
		<li>Though ideal, the head cuticle may not be fully removed in one step. In this case, remove the cuticle piece-by-piece until the brain is fully exposed. Take care not to damage the brain by avoiding direct contact with the forceps.</li>
	</ol>
	</li>
	<li>Remove the dissected brain from the PBS/T either by grabbing ahold of an attached trachea or by aspirating the brain into the space between the forceps tips by capillary action. 
	NOTE: Trachea removal is optional, as it tends not to obscure the antennal lobes on the anterior surface of the brain where we typically image. However, if the trachea interferes with imaging, remove them carefully so the brain is not damaged by this manipulation.</li>
	<li>Transfer the fly brain into one of the microcentrifuge tubes containing a fixative solution on ice. Ensure the brain detaches from the forceps and is submerged in the fixative solution.</li>
	<li>Once all of the brains have been dissected, subject them to a &#34;short-fix&#34; by placing the closed tubes on a nutator for ~ 5 min at room temperature in the dark. 
	&#8203;NOTE: This short fixation step ensures that the brains are easier to handle in subsequent steps and do not adhere to the sides of the microcentrifuge tube.</li>
	<li>Remove the majority of the fixative solution with a P1000 pipette and discard it.
	<ol>
		<li>Avoid aspirating brains from the tube during this and any subsequent wash step. Set the P1000 to a lower volume (e.g., 650 &#181;L) and remove the supernatant in two steps. In addition, hold the microcentrifuge tubes in line with a light source (e.g. overhead lights) while aspirating to visualize the brains better.</li>
	</ol>
	</li>
	<li>Add 1 mL of fresh PBS/T to the brains. Wash quickly (&#60; 1 min) in the dark, aspirate the supernatant from the brains, and discard.</li>
	<li>Repeat the washing with PBS/T in the dark at room temperature according to the following schedule: 2 quick (&#60; 1 min) washes, 1 X 5 min, 3 X 20 min, and 1 X 1 h wash. Secure tops on microcentrifuge tubes and place the tubes on a nutator in between washes.
	<ol>
		<li>If DAPI staining is desired, replace the final 1 h wash with 1 X 30 min incubation with 250 ng/mL DAPI diluted in PBS/T, followed by 2 X quick and 1 X 20 min washes.</li>
	</ol>
	</li>
	<li>After the last wash, remove the majority of the wash buffer supernatant, taking care not to disturb the brains, and add 30 &#181;L of glycerol-based antifade reagent to the brains. Incubate at 4 &#176;C in the dark without movement for at least 1 h and up to 24 h.</li>
</ol>
3. Whole Brain Mounting
<ol>
	<li>Place a glass microscope slide under a dissecting microscope and label it with identifying information. 
	&#8203;NOTE: Alternatively, the brains can be mounted directly onto a cover glass to access both sides of the brain during imaging. A protocol describing this mounting procedure has been previously published45.</li>
	<li>Remove the brains from each microcentrifuge tube using a blunted pipet tip (prepared using a razor blade to remove the bottom ~ 1 cm off a 1-200 &#181;L tip) and transfer them into the middle of the slide. Transfer as little antifade reagent with the brains as possible.</li>
	<li>Use forceps to position the brains in the desired orientation (e.g., dorsal pointing towards the top of the slide and anterior surface facing up for imaging the antennal lobe). When orienting the brains, consider the light path of the microscope to be used for imaging them.</li>
	<li>Remove excess antifade reagent from the slide using the pointed corner of a folded lab tissue without disturbing the brains. Let the slide sit for ~ 5-10 min in the dark to allow the brains to adhere to the slide.</li>
	<li>Surround the fly brains with four small pieces of broken cover glass placed on each side of the brains to form a square that is ~ 19 mm x 19 mm. Place one edge of a 22 mm x 22 mm No. 1.5 cover glass just outside one of these small pieces of glass, and gently lower the coverslip over the brains to complete the bridge-mount.</li>
	<li>Slowly dispense fresh antifade reagent to fill the surface beneath the coverslip, being careful not to disturb the coverslip or the brains. Wipe off any excess antifade using the pointed corner of a folded lab tissue without directly contacting the coverslip.</li>
	<li>Add a drop of clear, quick-drying nail polish to each of the four corners of the coverslip. Allow to dry for ~ 10 min. Then, seal the four edges of the coverslip with nail polish to completely enclose the brains.</li>
	<li>Image brains immediately or store at 4 &#176;C until ready.
	<ol>
		<li>If imaging intrinsic fluorescence from Htt-fluorescent protein fusions, image the brains within 24 h for the best signal.</li>
	</ol>
	</li>
</ol>
4. Imaging and Quantifying Prion-like Transmission of Aggregates
<ol>
	<li>Image the mounted brains using a confocal microscope equipped with a 40X or 60/63X oil objective to collect z-slice images through the region of the brain where the selected Gal4 and QF drivers are expressed (Figure 2A, B).
	<ol>
		<li>Excite the fluorescent protein fusions or immunolabeled proteins using the appropriate lasers (e.g., 488 nm for GFP/YFP/FITC or 552 nm for mCherry/Cy3). Set detection windows that capture a maximum fluorescent signal while eliminating channel cross-talk using either a spectral detection system or band/long pass emission filters specific for each fluorophore. 
		&#8203;NOTE: Be attentive when imaging protein aggregates. It is easy for pixels in the center of each aggregate to become saturated, especially in larger aggregates. Attempt to minimize saturation in the image, but be aware of the risk of losing signal from smaller aggregated species (Figure 2B, C, D). Too much saturation will increase the image background, making it more difficult to identify isolated puncta. Test different imaging settings to optimize before taking the final images in each data set.</li>
	</ol>
	</li>
	<li>Analyze the data by quantifying individual puncta either manually by moving through individual z-slices (e.g., Figure 2C and Figure 4A) or after rendering the confocal slices in 3 dimensions (Figure 3A, B). 
	NOTE: This can be done in Image J or other image processing software.
	<ol>
		<li>If the aggregates are well-separated and there is minimal background fluorescence, use image analysis software to systematically identify, quantify, and analyze the aggregates as distinct &#34;objects&#34; or &#34;surfaces&#34; in a 3D reconstruction of the confocal stack (Figure 3B). 
		NOTE: Software actions described are specific to the instrument and software used here (see the Table of Materials).
		<ol>
			<li>Visualize a confocal z-series in 3D viewing mode. Use the &#34;Analysis&#34; wizard to identify individual spots in a selected channel (e.g., the red channel for HttQ91-mCherry aggregates in Figure 3). Adjust the thresholding and filters to accurately represent all heterogeneously-sized aggregates as individual objects in the image.</li>
			<li>Enable &#34;Split objects&#34; under &#34;Binary Processing Pre-Filter&#34; to separate closely associated aggregates that are aberrantly merged by the software algorithm. Note that the total number of objects and their associated measurements is reported under &#34;Measurements.&#34; 
			NOTE: This method for quantifying mutant Htt aggregates is not amenable to the immunostaining protocol because the center of amyloid aggregates is impenetrable to antibodies. As a result, the aggregates appear on the microscope as ring-like structures and image analysis software is unable to identify and distinguish these individual &#34;spots accurately&#34;.</li>
		</ol>
		</li>
		<li>Quantify wild-type Htt aggregates by manually moving through the z-stack and scoring wild-type Htt aggregates, ensuring no aggregates are double-scored if they appear in more than one slice (Figure 4A). 
		NOTE: This manual quantification approach can be used when the number of aggregates in each confocal stack is reasonable (e.g., 20-50). It is also helpful when image analysis software cannot distinguish individual puncta from surrounding signal in the same channel (e.g., the signal from diffuse wild-type Htt in nearby cells) (Figure 2B, C and Figure 4A). Quantifying wild-type Htt aggregates can also be challenging because many normal structures in the brain appear punctate (e.g., cell processes and synapses). Co-localization of wild-type and mutant Htt signals can be used as a selection criterion; however, it is possible that some mutant Htt &#34;seeds&#34; fall below the limit of detection of the confocal. A protein other than Htt that does not aggregate in the recipient cells (e.g., GFP) can be used to label unrelated punctate structures in the brain.</li>
	</ol>
	</li>
	<li>Use image analysis software to perform further characterization of individual aggregates. For example, determine the size distribution of the aggregates (Figure 3C), percent co-localization between mutant and wild-type Htt proteins (Figure 4A), or directly measure protein-protein interactions using FRET (Figure 4B).
	<ol>
		<li>Determine the size distribution of individual puncta using a spot or surface detection algorithm that accurately identifies all visible aggregates in a particular channel. Use the image analysis software to take relevant measurements of the spots or surfaces, for example obtain &#39;aggregate diameter&#39; (Fig. 3C), &#39;volume&#39;, or &#39;intensity&#39; information from &#39;Measurements&#39; in the software &#34;Analysis&#34; wizard described in step 4.2.1. 
		NOTE: In Figure 3C, we report the distribution of diameters for all HttQ91-mCherry puncta identified in a single DA1 glomerulus.</li>
		<li>Determine the percent co-localization between HttQ25-YFP and HttQ91-mCherry aggregates by manually moving slice-by-slice through a confocal z-stack (the most accurate method). However, take care not to count any aggregates twice. To prevent this, only count aggregates in a particular z-slice if the plane of focus is through the center of the aggregate (Figure 4A).</li>
		<li>Calculate FRET efficiency for induced HttQ25-YFP aggregates with colocalized HttQ91-mCherry signal using the acceptor photobleaching method.
		<ol>
			<li>First, eliminate potential cross-talk between YFP and mCherry channels by establishing detection windows for mCherry-only and YFP-only signals that produce no signal in the other channel. Using these settings, take a &#39;before image&#39; of individual HttQ25-YFP puncta and their associated HttQ91-mCherry signal ( Figure 4B).</li>
			<li>Then, photobleach the mCherry signal by adjusting the red laser (e.g., 552 nm) to 100% intensity and scan until the signal is gone. Revert to the settings used for the &#39;before image,&#39; and take an &#39;after image&#39; of the same puncta (Figure 4B).</li>
			<li>Calculate fluorescence intensity measurements for each punctum before and after photobleaching using image analysis software.</li>
			<li>Calculate FRET efficiency by subtracting YFP donor fluorescence measured in the &#39;before image&#39; (YFPinitial) from YFP donor fluorescence in the &#39;after image&#39; (YFPfinal). Divide this value by YFPfinal, and multiply by 100. 
			NOTE: FRET efficiency can be calculated pixel-by-pixel or overall for each HttQ25-YFP aggregate (Figure 4B). Acceptor photobleaching is a particularly useful technique for calculating FRET efficiency when the mCherry signal associated with each HttQ25-YFP punctum is sufficiently high to produce detectable YFP dequenching after mCherry photobleaching.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Phosphate buffered saline (PBS), 10X, pH 7.4</td>
			<td>ThermoFisher Scientific</td>
			<td>AM9625</td>
			<td>Dilute to 1X</td>
		</tr>
		<tr>
			<td>Triton X-100</td>
			<td>Sigma-Aldrich</td>
			<td>T9284-1L</td>
			<td></td>
		</tr>
		<tr>
			<td>Kimwipes</td>
			<td>Thomas Scientific</td>
			<td>2904F24</td>
			<td></td>
		</tr>
		<tr>
			<td>20% paraformaldehyde (PFA)</td>
			<td>Electron Microscopy Sciences</td>
			<td>15713-S</td>
			<td></td>
		</tr>
		<tr>
			<td>Normal Goat Serum (NGS), filtered</td>
			<td>Lampire Biological Laboratories</td>
			<td>7332500</td>
			<td>Aliquot and freeze upon receipt</td>
		</tr>
		<tr>
			<td>Chicken anti-GFP</td>
			<td>Aves Labs</td>
			<td>GFP-1020</td>
			<td>Use at 1:500 dilution</td>
		</tr>
		<tr>
			<td>Rabbit anti-DsRed</td>
			<td>Clontech</td>
			<td>632496</td>
			<td>Use at 1:2000 dilution; can recognize DsRed-based fluorescent proteins (e.g. mCherry, mStrawberry, tdTomato, etc.)</td>
		</tr>
		<tr>
			<td>Mouse anti-Bruchpilot</td>
			<td>Developmental Studies Hybridoma Bank</td>
			<td>nc82</td>
			<td>Use at 1:100 dilution; will label active pre-synaptic structures thoughout the fly brain</td>
		</tr>
		<tr>
			<td>FITC anti-chicken</td>
			<td>ThermoFisher Scientific</td>
			<td>SA1-7200</td>
			<td>Use at 1:250 dilution</td>
		</tr>
		<tr>
			<td>Alexa Fluor 568 anti-rabbit</td>
			<td>Life Technologies</td>
			<td>A11011</td>
			<td>Use at 1:250 dilution</td>
		</tr>
		<tr>
			<td>Alexa Fluor 647 anti-mouse antibody</td>
			<td>Life Technologies</td>
			<td>A21235</td>
			<td>Use at 1:250 dilution</td>
		</tr>
		<tr>
			<td>Slowfade Gold Antifade Reagent</td>
			<td>Life Technologies</td>
			<td>S36936</td>
			<td></td>
		</tr>
		<tr>
			<td>Microscope Slides (25 x 75 x 1.0 mm)</td>
			<td>Fisher Scientific</td>
			<td>12-550-143</td>
			<td></td>
		</tr>
		<tr>
			<td>Cover Glass (22 x 22 mm)</td>
			<td>Globe Scientific</td>
			<td>1404-15</td>
			<td></td>
		</tr>
		<tr>
			<td>Dumont Biology Grade Forceps, Style 3</td>
			<td>Ted Pella</td>
			<td>503</td>
			<td>use in non-dominant hand</td>
		</tr>
		<tr>
			<td>Dumont Biology Grade Forceps, Style 5</td>
			<td>Ted Pella</td>
			<td>505</td>
			<td>use in dominant hand</td>
		</tr>
		<tr>
			<td>LAS X image analysis software</td>
			<td>Leica</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Imaris image analysis software</td>
			<td>Bitplane</td>
			<td></td>
			<td></td>
		</tr>
	</tbody>
</table>

imaging and quantification of protein aggregates in genetically modified drosophila brains

Source: Donnelly, K. M., et al. <a href="https://app.jove.com/v/56906">Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster.</a> J. Vis. Exp. (2018)
This video demonstrates imaging and quantification of protein aggregates in genetically modified Drosophila brains. Brains are fixed, washed, and treated with an antifading agent before mounting. Images are captured using a confocal microscope and quantified to observe the transmission of mutant protein aggregates.

<img alt="Figure 1" src="/files/ftp_upload/23091/23091_Figure1.jpg" /> 
Figure 1. A genetic approach for coupled expression of mutant and wild-type Htt transgenes using the QF-QUAS and Gal4-UAS binary expression systems. In &#34;cell A,&#34;&#160; mCherry-tagged mutant Htt protein containing a pathogenic-length polyQ stretch (Q91) is expressed using a QF driver located downstream of a tissue-specific promoter A (&#34;PA&#34;). In &#34;cell B,&#34; a YFP-tagged wild-t...

Imaging and Quantification of Protein Aggregates in Genetically Modified Drosophila Brains

1. Coupling Gal4- and QF-mediated Htt Transgene Expression in Drosophila

	Collect and/or generate transgenic Drosophila melanogaster lines containing ...

Begin with genetically modified Drosophila brains. These brains express a red fluorescent-tagged mutant protein in the neuron that can spread to the surrounding glial cell, expressing the yellow fluorescent-tagged normal protein, causing their aggregation.&#160;
Add a fixative solution that preserves cellular integrity.
Remove the fixative and wash with a buffer.
Add an antifade reagent and incubate to prevent the fading of fluorescent signals.
Transfer the brains onto a slide and remove excess liquid.
Allow the brains to adhere to the slide.
Using small pieces of a coverslip as spacers, place a coverslip on top of them. Add antifade reagent and seal it.
Under a confocal microscope, capture images using different excitation wavelengths for red and yellow fluorescence.
Using image analysis software, quantify the protein aggregates.
Co-localization of red and yellow fluorescence indicates the spreading of mutant proteins.

imaging-quantification-protein-aggregates-genetically-modified

Research

JoVE Encyclopedia of Experiments

Neuroscience

Neuropathology

Neurodegenerative Diseases

47 ビュー. 出典: Donnelly, K. M., et al. Watching Cell-to-Cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster. J. Vis. Exp.(2018年) このビデオでは、遺伝子組み換えショウジョウバエの脳におけるタンパク質凝集体のイメージングと定量を示しています。脳を固定し、洗浄し、埋込前に退色防止剤で処理します。画像は共焦点顕微鏡を使用して取得され、定量化されて変異タンパク質凝集体?...

ビデオ: 遺伝子組み換えショウジョウバエの脳におけるタンパク質凝集体のイメージングと定量 - 概念

Preparing Adult Drosophila melanogaster for Whole Brain Imaging during Behavior and Stimuli Responses

We present a method developed specifically to image the whole Drosophila brain during ongoing behavior such as walking. Head fixation and dissection are optimized to minimize their impact on behavior. This is first achieved by using a holder that minimizes movement hindrances. The back of the fly&#8217;s head is glued to this holder at an angle that allows optical access to the whole brain while retaining the fly&#8217;s ability to walk, groom, smell, taste and see. The back of the head is dissected to remove tissues in the optical path and muscles responsible for head movement artefacts. The fly brain can subsequently be imaged to record brain activity, for instance using calcium or voltage indicators, during specific behaviors such as walking or grooming, and in response to different stimuli. Once the challenging dissection, which requires considerable practice, has been mastered, this technique allows to record rich data sets relating whole brain activity to behavior and stimulus responses.

Preparing Adult Drosophila melanogaster for Whole Brain Imaging during Behavior and Stimuli Responses

We present a method specifically tailored to image the whole brain of adult Drosophila during behavior and in response to stimuli. The head is positioned to allow optical access to the whole brain, while the fly can move its legs and the antennae, the tip of the proboscis, and the eyes can receive sensory stimuli.

行動と刺激反応の間に全脳イメージングのための成人ショ ウジョウバエメラノガスター を準備する

We present a method developed specifically to image the whole Drosophila brain during ongoing behavior such as walking. Head fixation and dissection are ...

JoVE Journal

神経科学

Detection of Abnormal Prion Protein by Immunohistochemistry

Abnormal prion proteins (PrPSc) are the disease-associated isoform of cellular prion protein and diagnostic markers of transmissible spongiform encephalopathies (TSEs). These neurodegenerative diseases affect humans and several animal species and include scrapie, zoonotic bovine spongiform encephalopathy (BSE), chronic wasting disease of cervids (CWD), and the newly identified camel prion disease (CPD). Diagnosis of TSEs relies on immunodetection of PrPSc by application of both immunohistochemistry (IHC) and western immunoblot methods (WB) on encephalon tissues, namely, the brainstem (obex level). IHC is a widely used method that uses&#160;primary antibodies (monoclonal or polyclonal) against antigens of interest in cells of a tissue section. The antibody-antigen binding can be visualized by a color reaction that remains localized in the area of the tissue or cell where the antibody was targeted. As such, in prion diseases, as in other fields of research, the immunohistochemistry techniques are not solely used for diagnostic purposes but also in pathogenesis studies. Such studies involve detecting the PrPSc patterns and types from those previously described to identify the new prion strains. As BSE can infect humans, it is recommended that biosafety laboratory level-3 (BSL-3) facilities and/or practices are used to handle cattle, small ruminants, and cervid samples included in the TSE surveillance. Additionally, containment and prion-dedicated equipment are recommended, whenever possible, to limit contamination. The PrPSc IHC procedure consists of a formic acid epitope-demasking step also acting as a prion inactivation measure, as formalin-fixed and paraffin-embedded tissues used in this technique remain infectious. When interpreting the results, care must be taken to distinguish non-specific immunolabeling from target labeling. For this purpose, it is important to recognize artifacts of immunolabeling obtained in known TSE-negative control animals to differentiate those from specific PrPSc immunolabeling types, which can vary between TSE strains, host species, and prnp genotype, further described herein.

Immunolabeling abnormal prion protein using immunohistochemistry protocols requires specific sample and anti-PrP antibody preparation methodologies. The present protocol describes the key steps in epitope demasking to ensure proper PrP immunolabeling and to minimize non-specific background staining. Also, this approach considers biosafety measures when conducting immunohistochemistry studies with the prion-infected tissues.

Imaging and Quantification of Protein Aggregates in Genetically Modified Drosophila Brains

記録

Imaging and Quantification of Protein Aggregates in Genetically Modified Drosophila Brains